1. Home
  2. ATS vs VCEL Comparison

ATS vs VCEL Comparison

Compare ATS & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$19.45

Market Cap

2.6B

Sector

N/A

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$39.10

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATS
VCEL
Founded
1978
1989
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.4B
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
ATS
VCEL
Price
$19.45
$39.10
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$35.00
$57.75
AVG Volume (30 Days)
216.1K
430.3K
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
N/A
N/A
Revenue
N/A
$276,259,000.00
Revenue This Year
$17.99
$19.40
Revenue Next Year
$4.52
$18.24
P/E Ratio
$222.92
N/A
Revenue Growth
N/A
16.45
52 Week Low
$18.41
$28.95
52 Week High
$35.82
$49.32

Technical Indicators

Market Signals
Indicator
ATS
VCEL
Relative Strength Index (RSI) 37.27 29.87
Support Level $19.14 $35.45
Resistance Level $20.11 $39.48
Average True Range (ATR) 0.50 1.14
MACD 0.29 -0.31
Stochastic Oscillator 53.24 1.46

Price Performance

Historical Comparison
ATS
VCEL

About ATS ATS Corporation

ATS Corp is engaged in planning, designing, building, commissioning and servicing automated manufacturing systems - including automation products and test solutions - for a broadly diversified base of customers. The company focuses in five key markets: life sciences, food & beverage, transportation, consumer products and energy. The Company's operations are reported as one operating segment, Automation Systems, which plans, allocates resources, builds capabilities and implements practices on a world-wide basis. The company has presence in Canada, United States, Germany, Italy, Other Europe, and Other.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: